Canada’s Regulators Hold J&J Vaccine Over Emergent Link

The step was taken after Health Canada learned that an active ingredient was made in a Baltimore plant with contamination problems.

This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.

Accept Learn more…